Nuclear Antigen Antikörper
Kurzübersicht für Nuclear Antigen Antikörper (ABIN6297662)
Target
Alle Nuclear Antigen (IPO-38) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse anti-Human/Mouse/Rat IPO38 Antibody (Proliferation Marker) [Sodium Azide Free]
-
Spezifität
- Nuclear
-
Aufreinigung
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO38 antibody.
-
Immunogen
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO38 antibody.
-
-
anti-Nuclear Antigen (IPO-38) antibody
IPO-38 Reaktivität: Human, Maus, Ratte FACS, IF, IHC, StM Wirt: Maus Monoclonal SPM260 unconjugated
anti-Nuclear Antigen (IPO-38) antibodyIPO-38 Reaktivität: Human, Maus, Ratte FACS, IF, IHC (p) Wirt: Maus Monoclonal IPO-38 unconjugated
-
-
Applikationshinweise
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- Nuclear Antigen (IPO-38)
-
Andere Bezeichnung
- IPO38
-
Hintergrund
-
Target Description: Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 can be a useful marker of cell proliferation during monitoring of tumor progression.
Target
-
